Saturday, April 18, 2026

Technology

An Undervalued Biotech Showing Promise

Once you review this piece, consider buying or watch listing this unique biopharmaceutical company. The company's focus is therapy and, eventually, possibly, a cure...

OSTX’s OST-HER2: A Potential Game-Changer for Osteosarcoma (NYSE-A: OSTX)

ROCKVILLE, Md. & NEW YORK, August 02, 2024--(BUSINESS WIRE)--OS Therapies Incorporated ("OS Therapies" or the "Company") (NYSE-A: OSTX), a Cancer Immunotherapy and Antibody Drug Conjugate...

CULT Food Science Corp: Revolutionizing the Food Industry with Lab-Grown Meat (CSE: CULT, OTC: CULTF, FRA: LN0)

CULT Food Science Corp. ("CULT" or the "Company") (CSE: CULT) (OTC: CULTF) (FRA: LN0) is a disruptive food technology platform pioneering the commercialization of lab-grown meat and...

NurExone Biologic Advances Glaucoma Research with Cutting-Edge Exosome-Based Therapies (TSXV: NRX, OTCQB: NRXBF)

TORONTO and HAIFA, Israel, June 28, 2024 (GLOBE NEWSWIRE) -- NurExone Biologic Inc. (TSXV: NRX), (OTCQB: NRXBF), (Germany: J90) (the “Company” or “NurExone”), a...

NurExone Biologic Inc. Accelerates Growth with Dr. Yona Geffen’s Expertise (TSXV: NRX, OTCQB: NRXBF)

NurExone Biologic Inc TORONTO and HAIFA, Israel, June 21, 2024 (GLOBE NEWSWIRE) -- NurExone Biologic Inc. (TSXV: NRX), (OTCQB: NRXBF), (Germany: J90 is a pioneering...

Popular

Subscribe